Cervical Ca PROs in Clinical Practice

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 27, 2017

Primary Completion Date

May 25, 2020

Study Completion Date

May 25, 2020

Conditions
Cervical CancerRadiation Therapy
Interventions
OTHER

EORTC QLQ CX-24

Disease specific Patient Reported Outcome measurement tool developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire covers symptoms common to women with cervical cancer and captures the impact of disease and/or treatment on domains including: urologic and gastro-intestinal symptoms, sexual functioning and body image.

OTHER

Physician Feedback Form

This Feedback form to be completed by oncologists who have had at least one consenting patient participating in this study.

Trial Locations (3)

L4M 6M2

Royal Victoria Regional Health Centre, Barrie

M4N 3M5

Sunnybrook Research Institute, Toronto

Unknown

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03048435 - Cervical Ca PROs in Clinical Practice | Biotech Hunter | Biotech Hunter